journal
https://read.qxmd.com/read/38619045/human-amniotic-epithelial-cell-transplantation-is-safe-and-well-tolerated-in-patients-with-compensated-cirrhosis-a-first-in-human-trial
#1
JOURNAL ARTICLE
Rebecca Lim, Alexander Hodge, Sherryne Warner, Gregory T Moore, Jeanne Correia, Mirja Krause, Hannah McDonald, Siow T Chan, Mihiri Goonetilleke, Stuart M Lyon, William Sievert
Placenta-derived human amniotic epithelial cells (hAEC) exhibit anti-inflammatory and anti-fibrotic effects in cirrhosis models. We conducted a first-in-human phase I clinical trial to assess the safety and tolerability of hAEC in adults with compensated cirrhosis. We examined increasing and repeated doses of hAEC in 9 patients in 3 cohorts. Cohort 1 patients received 0.5 × 106/kg hAEC in one IV infusion. Cohort 2 patients received 1 × 106/kg hAEC in one IV infusion. The patients in cohort 3 received 1 × 106/kg hAEC on days 0 and 28...
April 15, 2024: Stem Cells Translational Medicine
https://read.qxmd.com/read/38606986/nasal-septum-derived-chondroprogenitor-cells-control-mandibular-condylar-resorption-consequent-to-orthognathic-surgery-a-clinical-trial
#2
JOURNAL ARTICLE
Ricardo de Souza Tesch, Esther Rieko Takamori, Karla Menezes, Rosana Bizon Vieira Carias, Carmen Lucia Kuniyoshi Rebelatto, Alexandra Cristina Senegaglia, Debora Regina Daga, Leticia Fracaro, Anny Waloski Robert, Carlos Bruno Reis Pinheiro, Marcelo de Freitas Aguiar, Pablo Javier Blanco, Eduardo Guerreiro Zilves, Paulo Roberto Slud Brofman, Radovan Borojevic
Condylar resorption is an aggressive and disability form of temporomandibular joint (TMJ) degenerative disease, usually non-respondent to conservative or minimally invasive therapies and often leading to surgical intervention and prostheses implantation. This condition is also one of the most dreaded postoperative complications of orthognathic surgery, with severe cartilage erosion and loss of subchondral bone volume and mineral density, associated with a painful or not inflammatory processes. Because regenerative medicine has emerged as an alternative for orthopedic cases with advanced degenerative joint disease, we conducted a phase I/IIa clinical trial (U1111-1194-6997) to evaluate the safety and efficacy of autologous nasal septal chondroprogenitor cells...
April 12, 2024: Stem Cells Translational Medicine
https://read.qxmd.com/read/38588471/human-in-vitro-models-of-neuroenergetics-and-neurometabolic-disturbances-current-advances-and-clinical-perspectives
#3
JOURNAL ARTICLE
Julia Rogal, Laura Nicoleti Zamproni, Polyxeni Nikolakopoulou, Sofia Ygberg, Anna Wedell, Anna Wredenberg, Anna Herland
Neurological conditions conquer the world; they are the leading cause of disability and the second leading cause of death worldwide, and they appear all around the world in every age group, gender, nationality, and socioeconomic class. Despite the growing evidence of an immense impact of perturbations in neuroenergetics on overall brain function, only little is known about the underlying mechanisms. Especially human insights are sparse, owing to a shortage of physiologically relevant model systems. With this perspective, we aim to explore the key steps and considerations involved in developing an advanced human in vitro model for studying neuroenergetics...
April 8, 2024: Stem Cells Translational Medicine
https://read.qxmd.com/read/38584493/transcriptomic-analysis-reveals-the-anti-cancer-effect-of-gestational-mesenchymal-stem-cell-secretome
#4
JOURNAL ARTICLE
Salvatore Vaiasicca, Gianmarco Melone, David W James, Marcos Quintela, Jing Xiao, Seydou Yao, Richard H Finnell, Robert S Conlan, Lewis W Francis, Bruna Corradetti
The environment created during embryogenesis contributes to reducing aberrations that drive structural malformations and tumorigenesis. In this study, we investigate the anti-cancer effect of mesenchymal stem cells (MSCs) derived from 2 different gestational tissues, the amniotic fluid (AF) and the chorionic villi (CV), with emphasis on their secretome. Transcriptomic analysis was performed on patient-derived AF- and CV-MSCs collected during prenatal diagnosis and identified both mRNAs and lncRNAs, involved in tissue homeostasis and inhibiting biological processes associated with the etiology of aggressive cancers while regulating immune pathways shown to be important in chronic disorders...
April 8, 2024: Stem Cells Translational Medicine
https://read.qxmd.com/read/38578768/long-term-outcome-following-treatment-with-allogeneic-mesenchymal-stem-stromal-cells-for-radiation-induced-hyposalivation-and-xerostomia
#5
JOURNAL ARTICLE
Kathrine Kronberg Jakobsen, Charlotte Duch Lynggaard, Natasja Paaske, Amanda-Louise Fenger Carlander, Jens Kastrup, Anne Werner Hauge, Robin Christensen, Christian Grønhøj, Christian von Buchwald
BACKGROUND: Adipose-derived mesenchymal stem/stromal cells (ASCs) are proposed as a new xerostomia treatment. The study evaluated the long-term safety and effectiveness of allogeneic ASCs in radiation-induced xerostomia among patients with previous oropharyngeal cancer. METHODS: This study constitutes 3-year follow-up on the original 10 patients who received allogeneic ASCs injections to the submandibular and parotid glands as part of the MESRIX-II trial. The MESRIX-II trial included the preliminary 4-month follow-up...
April 5, 2024: Stem Cells Translational Medicine
https://read.qxmd.com/read/38560897/donor-muse-cell-treatment-without-hla-matching-tests-and-immunosuppressant-treatment
#6
JOURNAL ARTICLE
Shinya Minatoguchi, Yasuyuki Fujita, Kuniyasu Niizuma, Teiji Tominaga, Toru Yamashita, Koji Abe, Mari Dezawa
The strength of stem cell therapy is the regeneration of tissues by synergistic pleiotropic effects. Among many stem cell types, mesenchymal stem cells (MSCs) that are comprised of heterogenous population are widely used for clinical applications with the expectation of pleiotropic bystander effects. Muse cells are pluripotent-like/macrophage-like stem cells distributed in the bone marrow, peripheral blood, and organ connective tissues as cells positive for the pluripotent surface marker stage-specific-embryonic antigen -3...
April 1, 2024: Stem Cells Translational Medicine
https://read.qxmd.com/read/38560893/influence-of-substrate-stiffness-on-ipsc-derived-retinal-pigmented-epithelial-cells
#7
JOURNAL ARTICLE
Rion J Wendland, Budd A Tucker, Kristan S Worthington
Retinal degenerative diseases are a major cause of blindness involving the dysfunction of photoreceptors, retinal pigmented epithelium (RPE), or both. A promising treatment approach involves replacing these cells via surgical transplantation, and previous work has shown that cell delivery scaffolds are vital to ensure sufficient cell survival. Thus, identifying scaffold properties that are conducive to cell viability and maturation (such as suitable material and mechanical properties) is critical to ensuring a successful treatment approach...
April 1, 2024: Stem Cells Translational Medicine
https://read.qxmd.com/read/38554123/study-on-the-extrapolability-of-current-tumorgenicity-test-with-mice-by-comparing-the-syngeneic-or-allogeneic-mouse-transplantation-model
#8
JOURNAL ARTICLE
Takashi Tamura, Tsuyoshi Tahara, Michiko Inoue, Ryota Nanjo, Hirotaka Onoe, Takako Yamamoto, Shin Kawamata
The extrapolability of the current tumorigenicity test performed by transplanting human cell product into immunodeficient (NOG) mice was investigated. For this purpose, the susceptibility to form teratomas of NOG mice was assessed by transplanting undifferentiated human-induced pluripotent stem cells (hiPSCs) as positive control cells via the liver, striatum, or tail vein and evaluating the TPD50 value (dose required to form teratomas in half of the transplanted mice). This was then compared to the TPD50 of syngeneic or allogeneic mouse models...
March 30, 2024: Stem Cells Translational Medicine
https://read.qxmd.com/read/38530131/precision-delivery-of-human-bone-marrow-derived-mesenchymal-stem-cells-into-the-pancreas-via-intra-arterial-injection-prevents-the-onset-of-diabetes
#9
JOURNAL ARTICLE
Rosita Primavera, Shobha Regmi, Reza Yarani, Steven Levitte, Jing Wang, Abantika Ganguly, Shashank Chetty, Michele Guindani, Camillo Ricordi, Everett Meyer, Avnesh S Thakor
Mesenchymal stem cells (MSCs) are a promising therapy to potentially treat diabetes given their potent anti-inflammatory and immune-modulatory properties. While these regenerative cells have shown considerable promise in cell culture, their clinical translation has been challenging. In part, this can be attributed to these cells not reaching the pancreas to exert their regenerative effects following conventional intravenous (IV) injection, with the majority of cells being trapped in the lungs in the pulmonary first-pass effect...
March 26, 2024: Stem Cells Translational Medicine
https://read.qxmd.com/read/38521608/impact-of-fda-s-hct-p-zikv-recommendations-on-cord-blood-unit-eligibility-and-utilization-in-a-large-public-cord-blood-bank
#10
JOURNAL ARTICLE
Dana S Guggenheim, Joanne Kurtzberg, Beth H Shaz
BACKGROUND: Cord blood units (CBUs) that are ineligible for licensure due to incomplete compliance with FDA recommendations may be used for hematopoietic stem cell transplantation under urgent medical need and an Investigational Drug Application. The largest reason for CBU donor ineligibility is Zika virus (ZIKV) risk. The study's objective was to analyze the impact of current FDA recommendations for ZIKA risk on a large public cord blood bank and propose updated recommendations. METHODS: We performed a retrospective analysis of Carolinas Cord Blood Bank (CCBB), an FDA licensed public CBB, using data from January 1, 2016 to November 21, 2023 and compared FDA recommendations for transfusion transmitted infections (TTI) for blood products and relevant communicable disease agents or diseases for human cell, tissue, or cellular or tissue-based products (HCT/Ps)...
March 23, 2024: Stem Cells Translational Medicine
https://read.qxmd.com/read/38513284/the-treatment-of-refractory-vitiligo-with-autologous-cultured-epithelium-grafting-a-real-world-retrospective-cohort-study
#11
JOURNAL ARTICLE
Jian Li, Xuanhao Zeng, Shujun Chen, Luyan Tang, Qi Zhang, Minzi Lv, Weiling Lian, Jinqi Wang, Haozhen Lv, Yating Liu, Jiayi Shen, Taro Uyama, Fuyue Wu, Jinfeng Wu, Jinhua Xu
BACKGROUND: Surgical intervention is the main therapy for refractory vitiligo. We developed a modified autologous cultured epithelial grafting (ACEG) technique for vitiligo treatment. Between January 2015 and June 2019, a total of 726 patients with vitiligo underwent ACEG in China, with patient characteristics and clinical factors being meticulously documented. Using a generalized linear mixed model, we were able to assess the association between these characteristics and the repigmentation rate...
March 21, 2024: Stem Cells Translational Medicine
https://read.qxmd.com/read/38507620/stem-cell-derived-extracellular-vesicle-therapy-for-multiple-sclerosis-a-systematic-review-and-meta-analysis-of-preclinical-studies
#12
JOURNAL ARTICLE
Mehri Barabadi, Madison C B Paton, Naveen Kumar, Rebecca Lim, Natalie L Payne
Stem cell therapy holds promise for multiple sclerosis (MS), with efficacy of different stem cell types reported across a range of preclinical MS animal models. While stem cell therapy has been approved for a small number of diseases in humans, extracellular vesicles (EVs) may provide an efficacious, cost-effective, and safer alternative to stem cell therapy. To this end, we conducted a systematic review with meta-analysis to assess the effectiveness of stem cell-derived secretome (EV and conditioned media (CM)) in animal models of MS...
March 20, 2024: Stem Cells Translational Medicine
https://read.qxmd.com/read/38502194/advances-in-3d-bioprinted-cardiac-tissue-using-stem-cell-derived-cardiomyocytes
#13
JOURNAL ARTICLE
Jacqueline M Bliley, Maria A Stang, Anne Behre, Adam W Feinberg
The ultimate goal of cardiac tissue engineering is to generate new muscle to repair or replace the damaged heart. This requires advances in stem cell technologies to differentiate billions of cardiomyocytes, together with advanced biofabrication approaches such as 3D bioprinting to achieve the requisite structure and contractile function. In this concise review, we cover recent progress in 3D bioprinting of cardiac tissue using pluripotent stem cell-derived cardiomyocytes, key design criteria for engineering aligned cardiac tissues, and ongoing challenges in the field that must be addressed to realize this goal...
March 19, 2024: Stem Cells Translational Medicine
https://read.qxmd.com/read/38459853/the-rejuvenation-and-functional-restoration-of-aged-adipose-stem-cells-by-duxap10-knockdown-via-the-regulation-of-the-mir-214-3p-rassf5-axis
#14
JOURNAL ARTICLE
Sen Ren, Chengcheng Li, Hewei Xiong, Qian Wu, Xiaohui Wu, Zhongwei Xiong, Lixing Dong, Bing Shu, Wei Wei, Chao Ma, Xiang Li, Jincao Chen
Adipose stem cell (ASC)-based therapies provide an encouraging option for tissue repair and regeneration. However, the function of these cells declines with aging, which limits their clinical transformation. Recent studies have outlined the involvement of long non-coding RNAs in stem cell aging. Here, we reanalyzed our published RNA sequencing (RNA-seq) data profiling differences between ASCs from young and old donors and identified a lncRNA named double homeobox A pseudogene 10 (DUXAP10) as significantly accumulated in aged ASCs...
March 9, 2024: Stem Cells Translational Medicine
https://read.qxmd.com/read/38457239/longitudinal-magnetic-resonance-imaging-tracking-of-transplanted-neural-progenitor-cells-in-the-spinal-cord-utilizing-the-bright-ferritin-mechanism
#15
JOURNAL ARTICLE
Zixiang Luo, Keyu Zhuang, Seong Jun Kim, Kyle D W Vollett, Zijian Lou, Jian Wang, Hai-Ying Mary Cheng, Mohamad Khazaei, Michael G Fehlings, Hai-Ling Margaret Cheng
Human neural progenitor cells (hNPCs) hold promise for treating spinal cord injury. Studies to date have focused on improving their regenerative potential and therapeutic effect. Equally important is ensuring successful delivery and engraftment of hNPCs at the injury site. Unfortunately, no current imaging solution for cell tracking is compatible with long-term monitoring in vivo. The objective of this study was to apply a novel bright-ferritin magnetic resonance imaging (MRI) mechanism to track hNPC transplants longitudinally and on demand in the rat spinal cord...
March 8, 2024: Stem Cells Translational Medicine
https://read.qxmd.com/read/38417110/recent-progress-in-photoreceptor-cell-based-therapy-for-degenerative-retinal-disease
#16
JOURNAL ARTICLE
Valeriia Klymenko, Orlando G González Martínez, Marco A Zarbin
Age-related macular degeneration and retinitis pigmentosa are degenerative retinal diseases that cause severe vision loss. Early clinical trials involving transplantation of photoreceptors as treatment for these conditions are underway. In this review, we summarize recent progress in the field of photoreceptor transplantation, including some pertinent results regarding photoreceptor manufacture, photoreceptor transplantation, mechanisms of donor-host cell integration such as material transfer and photoreceptor transplant immunology...
February 28, 2024: Stem Cells Translational Medicine
https://read.qxmd.com/read/38402590/manufacturing-parameters-for-the-creation-of-clinical-grade-human-induced-pluripotent-stem-cell-lines-from-umbilical-cord-mesenchymal-stromal-cells
#17
JOURNAL ARTICLE
Liziane Raquel Beckenkamp, Camila Gomes da Silva, Mônica Luiza Immig Von Hohendorff, Karolyn Sassi Ogliari
Induced pluripotent stem cells (iPSCs) are reprogrammed cells with a remarkable capacity for unlimited expansion and differentiation into various cell types. Companies worldwide are actively engaged in developing clinical-grade iPSC lines to address the needs of regenerative medicine, immunotherapies, and precision medicine. However, ensuring the safety and quality of iPSCs is essential, with adherence to Good Manufacturing Practices (GMP) and ethical considerations being paramount. Perinatal cell and tissue banks, such as umbilical cord (UC) blood and tissue banks, are emerging as ideal sources for generating iPSCs due to their unique characteristics and GMP compliance...
February 25, 2024: Stem Cells Translational Medicine
https://read.qxmd.com/read/38394392/recent-progress-in-retinal-pigment-epithelium-cell-based-therapy-for-retinal-disease
#18
JOURNAL ARTICLE
Valeriia Klymenko, Orlando G González Martínez, Marco Zarbin
Age-related macular degeneration and retinitis pigmentosa are degenerative retinal diseases that cause severe vision loss. Early clinical trials involving transplantation of retinal pigment epithelial cells and/or photoreceptors as a treatment for these conditions are underway. In this review, we summarize recent progress in the field of retinal pigment epithelium transplantation, including some pertinent clinical trial results as well as preclinical studies that address issues of transplant immunology, cell delivery, and cell manufacturing...
February 23, 2024: Stem Cells Translational Medicine
https://read.qxmd.com/read/38387017/curcumin-improves-functional-recovery-of-ruptured-tendon-by-promoting-tenogenesis-via-pi3k-akt-signaling
#19
JOURNAL ARTICLE
Zhan Zhang, Yiqun Zhang, Han Wang, Baolong Li, Rangjuan Cao, Yan Li, Shusen Cui, Weizhong Zhang
OBJECTIVE: In our previous study, we found that local release of curcumin from nanomicelles prevents peritendinous adhesion during Achilles tendon healing. The aim of this study is to further investigate the signaling integrated by curcumin to direct the tenogenetic program of tendon stem cells contributing to tendon healing. METHODS: A surgical model of tendon rupture and repair (TRR) was established in rats. Peritendinous adhesion and inflammation, biomechanical function, and expression of β-catenin and epithelial cellular adhesion molecule (EpCAM) were determined...
February 22, 2024: Stem Cells Translational Medicine
https://read.qxmd.com/read/38387006/agrin-inhibition-in-enteric-neural-stem-cells-enhances-their-migration-following-colonic-transplantation
#20
JOURNAL ARTICLE
Jessica L Mueller, Rhian Stavely, Richard A Guyer, Ádám Soos, Sukhada Bhave, Chris Han, Ryo Hotta, Nandor Nagy, Allan M Goldstein
Regenerative cell therapy to replenish the missing neurons and glia in the aganglionic segment of Hirschsprung disease represents a promising treatment option. However, the success of cell therapies for this condition are hindered by poor migration of the transplanted cells. This limitation is in part due to a markedly less permissive extracellular environment in the postnatal gut than that of the embryo. Coordinated interactions between enteric neural crest-derived cells (ENCDCs) and their local environment drive migration along the embryonic gut during development of the enteric nervous system...
February 22, 2024: Stem Cells Translational Medicine
journal
journal
43940
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.